Laurent Mineur

Laurent Mineur

UNVERIFIED PROFILE

Are you Laurent Mineur?   Register this Author

Register author
Laurent Mineur

Laurent Mineur

Publications by authors named "Laurent Mineur"

Are you Laurent Mineur?   Register this Author

45Publications

1876Reads

50Profile Views

[Supportive care for survivors].

Bull Cancer 2018 Sep 7;105(9):763-770. Epub 2018 Aug 7.

Institut Sainte-Catherine, 250, chemin de Baigne-Pieds, 84000 Avignon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2018.04.007DOI Listing
September 2018

Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.

J Clin Oncol 2018 05 5;36(15):1469-1477. Epub 2018 Apr 5.

Thierry André and Benoist Chibaudel, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris; Thierry André, Sorbonne Universités, UMPC Paris 06; Marine Hug de Larauze and Benoist Chibaudel and Thierry André, Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR); Christophe Louvet, Institut Mutualiste Montsouris; Céline Lepère, Hôpital Européen Georges Pompidou (HEGP); Gaël Deplanque, Groupe Hospitalier Saint-Joseph; Jean-Baptiste Bachet, Groupe Hospitalier Pitié Salpêtrière and Sorbonne Université, UMPC Paris 06; Ahmed Khalil, Hôpital Tenon; Julien Taieb, Hôpital Européen Georges Pompidou and Sorbonne Paris Cité, Université Paris Descartes, Paris; Julien Taieb, Fédération Française de Cancérologie Digestive; Jeremie Bez, Fédération Française de Cancérologie Digestive; François Ghiringhelli, Centre Georges-François Leclerc, Dijon; Dewi Vernerey and Sophie Paget-Bailly, CHU de Besançon; Serge Fratte, Hôpital de Besançon; Sophie Paget-Bailly, Franck Bonnetain and Dewi Vernerey INSERM UMR1098, Besançon; Laurent Mineur, Institut Sainte Catherine, Avignon; Jaafar Bennouna, Institut de Cancérologie de l'Ouest René Gauducheau, Saint-Herblain et Institut de Cancérologie Paul Papin, Angers; Jérôme Desrame, Hôpital Jean Mermoz, Lyon; Roger Faroux, Centre Hospitalier Départemental de La Roche sur Yon, La Roche sur Yon; Serge Fratte, Hôpital of Belfort-Montbeliard, Montbeliard; Jérôme Dauba, Centre Hospitalier Layné, Mont-de-Marsan; Olivier Dupuis, Clinique Victor Hugo, Le Mans; Yves Becouran, Institut Bergonié, Bordeaux; May Mabro, Hôpital Foch, Suresnes; Joëlle Egreteau, Centre Hospitalier de Bretagne Sud Site de Lorient, Lorient; Olivier Bouche, Hôpital Robert Debré, Reims; Marc Ychou, Institut du Cancer de Montpellier, and CHU de Montpellier, Montpellier; Marie Pierre Galais, Centre Francois Baclesse, Caen; Louis Marie Dourthe, Clinique Sainte Anne, Strasbourg; and Aimery de Gramont, Institut Hospitalier Franco-Britannique, Levallois-Perret, France.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.76.0355
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.76.0355DOI Listing
May 2018

[Hepatic myelolipoma: A rare entity, case report and review of the literature].

Ann Pathol 2017 Oct 19;37(5):415-419. Epub 2017 Sep 19.

Département de biopathologie cellulaire et tissulaire des tumeurs, équipe médicale anatomie et cytologie pathologiques, hôpital Gui-de-Chauliac, CHRU de Montpellier, 80, avenue Augustin-Fliche cedex 5, 34295 Montpellier Languedoc-Roussillon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2017.06.010DOI Listing
October 2017

Systemic chemotherapy with FOLFOX in metastatic grade 1/2 neuroendocrine cancer.

Mol Clin Oncol 2017 Jan 1;6(1):44-48. Epub 2016 Dec 1.

Department of Medical Oncology, Paoli-Calmettes Institute, 13009 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mco.2016.1097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245060PMC
January 2017

Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6).

J Clin Oncol 2016 11;34(31):3773-3780

Jérémie H. Lefevre, Salma Kotti, Yann Parc, Tabassome Simon, and Emmanuel Tiret, Hôpital Saint-Antoine, Assistance Publique Hôpitaux de Paris, Sorbonne Universités; Mehdi Karoui, Centre Hospitalier Universitaire (CHU) Pitié-Salpétrière; Anne Berger, CHU Hôpital Européen Georges-Pompidou; Jérome Loriau, Hôpital Saint-Joseph; Renato Lupinacci, Hôpital Croix Saint-Simon; Nicolas Goasgen, Hôpital des Diaconesses-Croix Saint-Simon, Paris; Laurent Mineur, Sainte-Camille Institut, Avignon; Eric Rullier, CHU Saint-André, Bordeaux; Philippe Rouanet, Val d'Aurelle Institut, Montpellier; Cécile de Chaisemartin, Paoli-Calmettes Institut, Marseille CHU, Marseille; Bernard Meunier, CHU Rennes, Rennes; Jafari Mehrdad, Oscar Lambret Center; Guillaume Piessen and Alain Saudemont, Centre Hospitalier Régional Universitaire, Lille; Eddy Cotte, CHU Lyon-Sud, Pierre-Bénite; Jérome Desrame, Jean Mermoz Institut, Lyon; Stéphane Benoist, CHU Bicètre, Le Kremlin-Bicêtre; Sylvain Kirzin, CHU Purpan, Toulouse; Yves Panis, Hôpital Beaujon, Université Paris VII, Clichy; Michel Prudhomme, CHU Carémeau, Nîmes; Frédérique Peschaud, CHU Ambroise-Paré, Boulogne-Billancourt; Anne Dubois, CHU Estaing, Clermont-Ferrand; Jean-Jacques Tuech, CHU, Rouen; and Guillaume Meurette, CHU Hôtel-Dieu, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.6049DOI Listing
November 2016

Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial.

JAMA Oncol 2016 May;2(5):643-653

Centre de Recherché UMR-S 1147, Médecine Personnalisée, Pharmacogénomique, Optimisation Thérapeutique, Institut National de la Santé et de la Recherche Médicale, Paris, France6Paris Descartes University, Department of Biology, European Georges Pompidou Ho.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.5225DOI Listing
May 2016

A phase III study evaluating oral glutamine and transforming growth factor-beta 2 on chemotherapy-induced toxicity in patients with digestive neoplasm.

Dig Liver Dis 2016 Mar 15;48(3):327-32. Epub 2015 Dec 15.

Department of Clinical Nutrition and Gastroenterology, Institut régional du Cancer de Montpellier (ICM), Montpellier, France; SIRIC Montpellier Cancer, Institut régional du Cancer de Montpellier (ICM), Montpellier, France; Epsylon Laboratory, EA 4556 Dynamics of Human Abilities & Health Behaviors, Université de Montpellier, Montpellier, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2015.11.025DOI Listing
March 2016

Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX.

Eur J Cancer 2016 Mar 2;56:115-121. Epub 2016 Feb 2.

Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR), Paris, France; Medical Oncology Department, Saint-Antoine Universitary Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.12.020DOI Listing
March 2016

Stereotactic Body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapy.

BMC Res Notes 2013 Nov 27;6:492. Epub 2013 Nov 27.

Department of Radiation Oncology and Surgical Oncology, Anticancer Centre Georges-François Leclerc, 21079 DIJON CEDEX, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-0500-6-492DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222093PMC
November 2013

First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer.

J Cancer Res Clin Oncol 2012 Jan 30;138(1):65-72. Epub 2011 Sep 30.

Department of Hematology and Oncology, Onkologie Klinikum Oldenburg, 26133, Oldenburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-011-1061-6DOI Listing
January 2012

Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer.

Cancer Chemother Pharmacol 2007 Aug 24;60(3):383-9. Epub 2006 Nov 24.

Digestive Department, CRLC Val d'Aurelle Parc Euromédecine, 34298 Montpellier Cedex 5, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-006-0372-9DOI Listing
August 2007

Chemotherapy with preoperative radiotherapy in rectal cancer.

N Engl J Med 2006 Sep;355(11):1114-23

Department of Radiation Therapy, University of Franche-Comté, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa060829DOI Listing
September 2006